Pancreatic trypsin output and plasma secretin and cholecystokinin (CCK) levels were measured in five healthy volunteers to investigate the mechanisms involved in regulating postprandial pancreatic secretion. and CCK by specific radioimmunoassays. Increasing doses of secretin produced increasing bicarbonate output (P < 0.01), whereas trypsin was not stimulated over basal. Graded caerulein produced a stepwise increase in trypsin and bicarbonate output (P < 0.01). Potentiation occurred for bicarbonate secretion between secretin and caerulein, but not for trypsin output. Postprandial trypsin secretion averaged 29.1 IU/min-' over 150 min (equal to 55% of maximal response to caerulein). The peak trypsin response amounted to 90% of maximal caerulein. Significant increases of plasma secretin (P < 0.05) and CCK (P < 0.01) were observed after the meal. Comparison of enzyme and CCK responses to the testmeal or to exogenous caerulein suggested that the amount of CCK released after the meal could account for the postprandial trypsin secretion. We conclude that (a) the postprandial enzyme response in man is submaximal in comparison to maximal exogenous hormone stimulation; (b) CCK is a major stimulatory mechanism of postprandial trypsin secretion, whereas secretin is not involved; and (c) Potentiation of enzyme secretion is not a regulatory mechanism of the postprandial secretory response.
Introduction
Despite a considerable number of studies on postprandial enzyme secretion in man, many questions remain unanswered. For example, the quantity of enzymes secreted after a meal in comparison to maximal exogenous hormone stimulation is not known (1) . Mechanisms regulating postprandial enzyme response are also controversial: hormonal and neural pathways have been assumed, but have not been investigated with respect to their relative contributions (1) . Furthermore, the role of potentiation as a regulating mechanism in the control of pancreatic secretion has to be clarified. While it is accepted that potentiation for pancreatic bicarbonate secretion between pancreatic secretagogues occurs in man (2, 3) , it is debated if such a mechanism exists for pancreatic enzyme secretion (3) (4) (5) . Finally, the physiological role of cholecystokinin (CCK),' one of the classical pancreatic hormones, has been questioned (6) (7) (8) . The development of specific and sensitive CCK radioimmunoassay (RIA) systems permitted the study of its physiological role. This prompted us to study in humans the following problems: (1) What is the pancreatic enzyme response to food compared with that of exogenous CCK? (2) (2.3-37 pmol/kg-' per h-') was infused simultaneously with secretin, each dose for 30 min. (d) After the basal period, the volunteers drank a liquid meal within 3 min. According to the manufacturer's analysis, the meal (400 ml) consisted of 21 g protein, 16 .6 g fat, and 78 g carbohydrates (mixture of one bag Meritene plus one bag Edarene in 400 ml of water). It had an osmolality of 550 mosmol/liter-' and a pH of 5.9.
The total caloric value was 2,300 kJ, which was equivalent to 565 kcal. In this study, gastric aspiration was discontinued after the basal period, but duodenal perfusion of PEG and aspiration continued.
In studies where exogenous hormones were given, blood samples for secretin and cholecystokinin RIA were obtained in duplicates at the baseline and at the end of each dose of each stimulant. During the meal study, blood was drawn at baseline and at 15-min intervals for 3 h. Blood was collected in ice-chilled tubes that contained 150 Aig EDTA and 5,000 KIU aprotinin per 5 ml blood. Samples were immediately centrifuged at 4VC and the plasma stored at -20'C until it was assayed.
Materials. Synthetic porcine secretin was a kind gift of Dr. Gillessen, F. Hoffmann-LaRoche & Co., Ltd., Basel, Switzerland. Synthetic caerulein was purchased from Farmitalia, Milan, Italy. Meritene and Edarene were kind gifts of Wander AG, Berne, Switzerland.
Determinations. Volume was measured to the next 0.1 ml; bicarbonate concentration of duodenal juice was determined by the backtitration method (9); and trypsin concentration was measured by the method of Wiggins using N-benzoyl-L-arginine-ethylester-hydrochloride as substrate (10) . PEG concentration was determined turbidimetrically by a modified method of Hyden (1 1).
Plasma secretin RIA. Plasma secretin was measured as previously described in detail (12) . In short, the secretin antibody was raised in rabbits. Synthetic secretin was used as standard and tracer. Secretin was labeled with a '25I by a modified lactoperoxidase method (12) . Labeled secretin was purified on a SP Sephadex C25 column. The specific radioactivity from different iodinations ranged from 400 to 800 gCi/nmol-'. Plasma was treated by ethanol extraction. The extraction recovery of plasma samples was 92±4% when 10 pg secretinpentacitrate was added per milliliter charcoal-stripped human plasma. The standards of synthetic secretin were prepared by adding 400 Ml of assay buffer with 0-30 fmol of secretin to tubes containing dried ethanol extracts of charcoal-stripped human plasma. The sensitivity of the assay was 0.3±0.02 pmol/liter-' plasma. No significant crossreactivity was observed with vasoactive intestinal polypeptide, gastric inhibitory polypeptide, and pancreatic glucagon. The intraassay and interassay variation was 11.9 and 15.5%, respectively, at 3.3 pmol/ liter'.
Plasma CCK RIA. Plasma CCK concentrations were estimated by a recently published specific RIA (7, (13) (14) (15) . Antibody T204 binds to all carboxyl-terminal CCK peptides containing the sulfated tyrosine. The antibody shows <2% cross-reactivity to sulfated gastrins and does not bind to unsulfated forms of gastrin (7, (13) (14) (15) . It does not crossreact with structurally unrelated gastrointestinal peptides as insulin, glucagon, secretin, pancreatic polypeptide, bombesin, or neurotensin.
CCK33 coupled to '25I-hydroxyphenylpropionic acid succinimide ester (Bolton-Hunter reagent) was used as label. The specific radioactivity ranged from 260 to 485 uCi/.ug-' (n = 8). 99% pure cholecystokinin 33 in the meal study and synthetic caerulein in the caerulein infusion study were used as standards. Dilution curves of 99% pure CCK and synthetic caerulein were parallel (Fig. 1) . A two-step incubation procedure was used. Separation between free and antibody-bound hormone was performed by a charcoal method. The 50% inhibition -dose was 3.3 pmol/liter-'. All plasma samples were treated by an ethanol extraction procedure. The extraction recovery of plasma samples was 85±2% when CCK33 and 90±2% when sulfated CCK8 was added to hormone-free plasma. The intraassay and interassay variation was 8.4
and 11.3%, respectively, at 2.6 pmol/liter-c. volume (ml/10 min-'); F is the flow rate of PEG solution perfused (2 ml/min-'); PEG perf is the concentration of PEG in the perfusate, and PEG meas is the concentration of PEG in the duodenal juice collected for 10 min. The recovery of the duodenal marker (PEG 4000) averaged 67% (range 57-71%). The average percentage of PEG 4000 recovered from the stomach was 5% (range 0-9%).
Results
Pancreatic secretion to hormonal stimulants. As expected, the infusion of graded doses of secretin produced increasing stimulation of pancreatic bicarbonate secretion. Even when given alone, the lowest dose of secretin (1 pmol/kg-' per h-') caused a statistically significant (P < 0.05) increase of bicarbonate output over basal values (the incremental bicarbonate response was 10±3 ,umol/min-'). The highest dose of secretin (82 pmol/ kg-' per h-') did not produce maximal bicarbonate secretion. Infusion of secretin produced small increases of trypsin output which were not statistically significant from basal values. Basal pancreatic bicarbonate secretion averaged 23±7 gmol/min-', whereas basal trypsin output amounted to 15±6 IU/min-'.
Given alone, the lowest dose of caerulein did not increase bicarbonate secretion above basal levels (basal trypsin output 10±4 IU/min'; basal bicarbonate output 16±3 Mmol/min-'); it did, however, significantly (P < 0.05) stimulate trypsin output (Table II) . The correlation between secretin doses infused and plasma secretin levels was: y = 1.09 + 0.47 x (r = 0.978, P < 0.01). 1 pmol/kg-' per h-' of secretin resulted in a small but significant (P < 0.05) elevation in plasma secretin levels (mean incremental increase: 0.8±0.3 pmol/liter-'). The plasma levels were not influenced by intravenous caerulein or addition of caerulein to intravenous secretin infusion (data not shown).
In the postprandial period, secretin concentration changed significantly (P < 0.05) in each volunteer. However, no sustained increase of plasma secretin was observed (Fig. 2) , but secretin release appeared to occur in spikes. The maximal postprandial secretin release over basal levels was 1.3±0.3 pmol/liter-' (P < 0.01), whereas the cumulative incremental postprandial secretin release amounted to 4.5±1.5 pmol/liter-' (P < 0.05).
Plasma CCK concentrations. Fasting plasma CCK levels were comparable in the different experiments (mean: 2.4±0.5 pmol/liter-'). Exogenous caerulein produced a dose-dependent increase in plasma CCKLI, which was significant for the second and all subsequent doses (Table III ). An excellent correlation between caerulein doses infused and plasma caerulein levels was obtained: y = 2.02 + 0.58 x, r = 0.980, P < 0.01.
After the testmeal, plasma CCK increased rapidly in each volunteer (P < 0.05). The peak response over basal values was For each volunteer, the incremental value (the increase over basal) represents the average of two plasma samples taken at the end of each dose. Basal values are calculated from the average of two samples in each test. The mean response represents the mean of 12 samples drawn during 180 min after feeding; the individual means were used to calculate a group mean and SE that is shown (n = 5).
3.7±0.4 pmol/liter-' and occurred between the 15th and 45th min after ingestion of the meal. CCK levels remained elevated until the end of the experiment, although they had a tendency to decline (Fig. 2) . The cumulative incremental CCK response to the testmeal amounted to 28.3±4.3 pmol/liter' (P < 0.01).
Discussion
It is generally accepted that the intestinal phase of the pancreatic secretory response to food is primarily mediated by neural and hormonal pathways that arise from the duodenal mucosa and are activated by digestive products. While the mechanisms responsible for pancreatic bicarbonate secretion have recently been elucidated to a considerable extent (17) (18) (19) (20) (21) (22) , those regulating the postprandial enzyme response have still to be defined. The role of cholecystokinin, one of the classical postulated hormonal regulators of pancreatic enzyme secretion, continues to be puzzlesome, however, despite the specific and sensitive RIA systems recently described (7, 8, (13) (14) (15) (23) (24) (25) (26) (27) (34) . No comparison was made with exogenous CCK in these studies. MacGregor and co-workers (35) reported that a liquid testmeal was itself a stimulus, with -60% of the efficacy of exogenous CCK. They did, however, not specify if this value refers to the mean secretory trypsin response or to the peak output. Assuming the first, our results would be quite similar to MacGregor's (mean trypsin output from 30 to 150 min = 55% of maximal), which suggests that the pancreas is very similar to the stomach: both secrete at submaximal rates in response to food (36) .
The plasma hormone data from this study provide new insight into the regulation of pancreatic enzyme secretion. Ingestion of the testmeal induced significant increases in plasma CCK and pancreatic trypsin secretion. The mean postprandial increase in plasma CCK was 2.4 pmol/liter-', while the mean postprandial trypsin response was 29.4 IU/ min-'. When a similar increase in plasma CCKLI (2.6 pmol/ liter-') was produced by infusion of 9.2 pmol/kg-' per h-' caerulein, the pancreatic trypsin response (31±3 IU/min-') was very similar to that found after the meal. These results suggest that the release of CCK could account for the postprandial trypsin secretion after this specific testmeal. This finding is in agreement with a recent study published in abstract form, which indicates that the release of CCK can exclusively account for the enzyme secretion in response to intestinal oleate in the dog (37) . It can be argued that caerulein is a synthetic CCK peptide that is not present in plasma under 1474 physiological circumstances. However, equimolar doses of CCK33 should produce similar results, as we have shown recently that on a molar basis caerulein and CCK33 are equipotent in stimulating enzyme secretion (38, 39) . Nevertheless, considering the interplay between stimulatory and inhibitory mechanisms under physiological conditions, caution is indicated with regard to conclusions based on analogy between hormone plasma levels measured after a meal and those measured during experimental hormone infusion.
It was further indicated in the present study that the small amounts of secretin released in response to the meal do not contribute to the postprandial pancreatic enzyme secretion, since infusion of secretin does neither stimulate enzyme secretion nor potentiate the effect of CCK on enzyme output from the pancreas. On the other hand, low doses of exogenous secretin can stimulate pancreatic bicarbonate secretion with concomitant increases in plasma secretin, which confirms a previous study (19) . Comparable secretin concentrations were detected postprandially, but no data can be given concerning pancreatic fluid or bicarbonate secretion owing to the technical problems involved in specifically measuring pancreatic bicarbonate secretion in response to food in man.
